Apremilast 30 mg Twice Daily (BID) Combined With Dupilumab

NCT04306965 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Apremilast

Sponsor

Tufts Medical Center

Collaborators

[object Object]